Hodgkinson, Neville
September 2001
Mothering;Sep/Oct2001, Issue 108, p66
Reports on the lethal dangers of the antiviral drug AZT, given to HIV-positive mothers in pregnancy and to their newborn babies. Basis for the AZT treatment strategy; Proven toxicities of the drug; Likelihood of rapid disease progression in babies born to mothers treated with the AZT drug.


Related Articles

  • A pilot study to evaluate the safely and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil. Lambert, J. S.; Nogueira, S. A.; Abreu, T.; Machodo, E. S.; Costa, T. P.; Bondarovsky, M.; Andrade, M.; Halpern, M.; Barbosa, R.; Perez, M. // Sexually Transmitted Infections;Dec2003, Vol. 79 Issue 6, p448 

    Objectives: To evaluate the safety and feasibility of zidovudine and lamivudine (AZT/3TC) given to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil. Methods: This open label phase II study enrolled 40 HIV infected antiretroviral naive women ⩽ 20 weeks gestation, CD4 <...

  • Lamivudine/nevirapine/zidovudine.  // Reactions Weekly;2/20/2010, Issue 1289, p25 

    The article describes the cases of three neonates who experienced lactic acidosis after in utero and postnatal exposure to antiretrovirals. The neonates received lamivudine, nevirapine and zidovudine. A 45-day-old girl was born to an HIV-positive mother and started receiving citrimoxazole. A...

  • Haematological Safety of Perinatal Zidovudine in Pregnant HIV-1--Infected Women in Thailand: Secondary Analysis of a Randomized Trial. Briand1, Nelly; Lallemant, Marc; Jourdain, Gonzague; Techapalokul, Somnuek; Tunthanathip, Preecha; Suphanich, Surachet; Chanpoo, Truengta; Traisathit, Patrinee; McIntosh, Kenneth; Le Coeur, Sophie // PLoS Clinical Trials;Apr2007, Vol. 4 Issue 4, p01 

    Objectives: To respond to the primary safety objective of the Perinatal HIV Prevention Trial 1 (PHPT-1) by studying the evolution of haematological parameters according to zidovudine exposure duration in HIV-1--infected pregnant women. Design: Multicenter, randomized, double-blind, controlled...

  • Stavudine/zidovudine.  // Reactions Weekly;6/6/2009, Issue 1255, p30 

    The article describes the case of a 60-year-old HIV-positive woman who developed hyperlactataemia while undergoing stavudine treatment and recurred upon switching to zidovudine. The patient, who received stavudine, lamivudine and nevirapine, presented with suspected hyperlactataemia. This...

  • Zidovudine Given to Infants Soon After Birth Reduces Perinatal HIV Transmission. Moore, M. // Family Planning Perspectives;Mar/Apr99, Vol. 31 Issue 2, p103 

    This article presents the results of an analysis of data on infants born in New York State between 1995 and 1997. When infants born to HIV-infected women are given zidovudine shortly after birth, they have a reduced risk of contracting the infection, even if their mothers did not receive...

  • Lamivudine/zidovudine/nelfinavir.  // Reactions Weekly;10/24/2009, Issue 1275, p21 

    The article describes the case of a 24-year-old HIV-positive pregnant woman who acquired fulminant liver failure. The patient developed the said condition while undergoing treatment with lamivudine, zidovudine and nelfinavir. The patient was subjected to liver transplantation and was given...

  • Zidovudine.  // Reactions Weekly;12/9/2006, Issue 1131, p34 

    The article presents case reports of intestinal obstruction in male neonates following in utero exposure to zidovudine for maternal HIV infection, with reference to a study by N. M. Brindley in the August 2006 issue of the "European Journal of Pediatric Surgery." All three neonates tolerated...

  • Antiretrovirals.  // Reactions Weekly;9/5/2009, Issue 1268, p7 

    The article describes the case of a 7-month-old HIV-positive girl who acquired immune reconstitution syndrome. The patient developed the said condition while undergoing Highly Active AntiRetroviral Therapy (HAART) with zidovudine, lamivudine and lopinavir/ritonavir. The patient was treated with...

  • PATOLOGIA CARDIOVASCULARÄ‚ LA COPIII PROVENIÅ¢I DIN MAME HIV POZITIVE. Cristea, Cosmina; Vlăsceanu, Andreia; Anca, Ioana Alina; Matei, D.; Gherghina, I.; Mărdărescu, Mariana // Romanian Medical Journal;2011, Vol. 58 Issue 2, p102 

    In the end of XX-th century, Romania had over 4000 orizontally HIV infected children. They have received anti- retroviral treatment, and now have children of their own. It is common knowledge that anti-retroviral treatments lead to side effects. The aim of the study is to determine if the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics